The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease

Abebaw Mengistu Yohannes
DOI: https://doi.org/10.1513/AnnalsATS.202206-525ED
2022-10-01
Abstract:Patients with chronic obstructive pulmonary disease (COPD) often exhibit dyspnea on exertion, manifested by reduced exercise capacity (EC), diminished physical activity (PA), and impaired quality of life (QOL). Comorbidities are common in patients with COPD, including cardiovascular disease, neuropsychiatric diseases, and metabolic disorders. These comorbidities may exacerbate to persistent smoking, sedentary lifestyle, and less desire to engage in PA, and they may accentuate systematic inflammation and heighten risks of emergency healthcare use (1). Of these, obesity (defined as body mass index [BMI] greater than 30 kg/m 2 ) affects 54% of patients with COPD in the United States at a relatively young age, and it elevates the risk of functional limitations (2). However, BMI is a crude (i.e., inexact) measure because it does not consider body composition (e.g., the amount of metabolically and functionally active fat-free mass [FFM] rather than body weight or fat mass [FM]); yet, obesity is positively (surprisingly) related to survival in patients with COPD (3).
respiratory system
What problem does this paper attempt to address?